The popular at-home red light therapy skincare treatment uses low-level wavelengths of red light to address various skin ...

MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI ) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Biogen (BIIB – Research Report) and keeping the price target at ...

AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Wedbush in a research ...

Alumis Inc. ( (ALMS) ) has released its Q3 earnings. Here is a breakdown of the information Alumis Inc. presented to its investors. Alumis ...

Winter itch is a common and discomforting cold weather problem, but some simple lifestyle changes can help to take care of the itch and prevent your skin from such issues.

Research analysts at HC Wainwright increased their FY2024 earnings per share (EPS) estimates for shares of FibroBiologics in a research note issued to investors on Wednesday, November 13th. HC ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human primate (NHP) pharmacokinetic and in vitro ...

At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 years the immunosuppressive drug has been on the market, it brought in ...

While countless long COVID sufferers put Pretorius’s theory to the test, her new focus is raising its awareness. Not only ...